Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2025-12-25 @ 3:16 AM
NCT ID:
NCT05296005
Eligibility Criteria:
Inclusion Criteria:
* Patients with histologically proven, cT2N0-T4aN3M0 (TNM 8th edition), gastric or Siewert II-III GEJ adenocarcinoma
* Evaluation with endoscopic ultrasound (EUS) and staging laparoscopy prior to enrollment is strongly recommended.
* Patient should be a candidate for neoadjuvant chemotherapy with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) or fluorouracil and oxaliplatin (FOLFOX).
* Patients should be \>= 18 years old
* Eastern Cooperative Oncology Group (ECOG) performance status =\< 2
* Patient should be eligible for surgical intervention
* T1 N0 disease (assessed by endoscopic ultrasound)
Exclusion Criteria:
* Evidence of distant metastatic disease
* Solitary functioning kidney within the potential radiation field
* Peripheral polyneuropathy \> National Cancer Institute (NCI) grade II
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05296005
Study Brief:
Protocol Section:
NCT05296005